SlideShare a Scribd company logo
1
Case-Control Studies
Dr. M. Ismail Zubair MD. MSc
2
Objectives - Concepts
• Define, understand and identify (CCS)
• Understand the principles of selecting cases and
controls
• Understand the analysis of CCS
• Calculation and interpretation of the OR
• Understand the concept of matching
• Understand the origin and consequence of recall bias
• Example of measurement bias
• Advantages and disadvantages of CCS
3
4
5
6
7
Case-Control Studies (CCS)
• An alternative observational design to identify risk
factors for a disease/outcome.
• Question:
• How do diseased cases differ from non-diseased (controls)
with respect to prior exposure history?
• Compare frequency of exposure among cases and controls
• Effect cause.
• Cannot calculate disease incidence rates because the CCS
does not follow a disease free- population over time
8
9
10
11
12
13
Disease
+ -
Exp + a b
Exp - c d
d 1 d 0
Case-control Study – Design
Select subjects on the basis of disease status
14
Example CCS - Smoking and Myocardial Infarction
MI
+ -
Smk + 30 20
Smk - 10 20
•
40 40
OR = a . d = 30 . 20 = 3.0 (same as the RR!)
c . b 10 . 20
Study: Desert island, population = 2,000 people, prevalence of
smoking = 50% [but this is unknown], identify all MI cases that
occurred over last year (N=40), obtain a random sample of N=40
controls (no MI). What is the association between smoking and MI?
15
Examples of CCS
• Outbreak investigations
• What dish caused people at the church picnic to get sick?
• What is causing young women to die of toxic shock?
• Birth defects
• Drug exposures and heart tetralogy
• New (unrecognized) disease
• DES and vaginal cancer in adolescents
• Is smoking the reason for the increase in lung CA? (1940’s)
– Four CCS implicating smoking and lung cancer appeared in
1950, establishing the CCS method in epidemiology
16
Essential features of CCS design
• Directionality
• Outcome to exposure
• Timing
• Retrospective for exposure, but case ascertainment can be either
retrospective or prospective.
• Rare or new disease
• Design of choice if disease is rare or if a quick “answer” is needed
(cohort design not useful)
• Challenging
• The most difficult type of study to design and execute
• Design options
• Population-based vs. hospital-based
17
Selection of Cases
• Requires case-definition:
• Need for standard diagnostic criteria e.g., AMI
• Consider severity of disease? e.g., asthma
• Consider duration of disease
– prevalent or incident case?
• Requires eligibility criteria
• Area of residence, age, gender, etc
18
Sources of Cases
• Population-based
– identify and enroll all incident cases from a defined population
– e.g., disease registry, defined geographical area, vital records
• Hospital-based
• identify cases where you can find them
– e.g., hospitals, clinics.
• But……
– issue of representativeness?
– prevalent vs incident cases?
19
Selection of Controls
• Controls reveal the ‘normal’ or ‘expected’ level of
exposure in the population that gave rise to the
cases.
• Issue of comparability to cases – concept of the
“study base”
• Controls should be from the same underlying population or
study base that gave rise to the cases?
• Need to determine if the control had developed disease
would he or she be included as a case in the study?
– If no then do not include
• Controls should have the same eligibility criteria as
the cases
20
Sources of Controls
• Population-based Controls
– ideal, represents exposure distribution in the general
population, e.g.,
• driver’s license lists (16+)
• Medicare recipients (65+)
• Tax lists
• Voting lists
• Telephone RDD survey
• But if low participation rate = response bias
(selection bias)
21
Sources of Controls
• Hospital-based Controls
• Hospital-based case control studies used when population-
based studies not feasible
• More susceptible to bias
• Advantages
– similar to cases? (hospital use means similar SES, location)
– more likely to participate (they are sick)
– efficient (interview in hospital)
• Disadvantages
– they have disease?
• Don’t select if risk factor for their disease is similar to the
disease under study e.g., COPD and Lung CA
– are they representative of the study base?
22
Other Sources of Controls
• Relatives, Neighbors, Friends of Cases
• Advantages
– similar to cases wrt SES/ education/ neighborhood
– more willing to co-operate
• Disadvantages
– more time consuming
– cases may not be willing to give information?
– may have similar risk factors (e.g., smoke, alcohol, golf)
23
Disease
case control
Exp + a b
Exp - c d
d 1 d 0
• Odds of exposure among cases = a / c
• Odds of exposure among controls = b / d
24
Analysis of CCS
The OR as a measure of association
• The only valid measure of association for the CCS is the
Odds Ratio (OR)
• Under reasonable assumptions (– the rare disease
assumption) the OR approximates the RR.
• OR = Odds of exposure among cases (disease)
Odds of exposure among controls (non-dis)
– Odds of exposure among cases = a / c
– Odds of exposure among controls = b / d
– Odds ratio = a/c = a.d [= cross-product ratio]
b/d b.c
25
Example CCS - Smoking and Myocardial Infarction
MI
+ -
Smk + 30 20
Smk - 10 20
•
40 40
OR = a . d = 30 . 20 = 3.0 (same as the RR!)
c . b 10 . 20
Study: Desert island, population = 2,000 people, prevalence of
smoking = 50% [but this is unknown], identify all MI cases that
occurred over last year (N=40), obtain a random sample of N=40
controls (no MI). What is the association between smoking and MI?
26
Odds Ratio (OR)
• Similar interpretation as the Relative Risk
• OR = 1.0 (implies equal odds of exposure - no effect)
• ORs provide the exact same information as the RR if:
• controls represent the target population
• cases represent all cases
• rare disease assumption holds (or if case-control study is undertaken with
population-based sampling)
• Remember:
• OR can be calculated for any design but RR can only be calculated in RCT
and cohort studies
• The OR is the only valid measure for CCS
• Publications will occasionally mis-label OR as RR (or vice versa)
27
Controlling extraneous variables
(confounding)
• Exposure of interest may be confounded by a
factor that is associated with the exposure
and the disease i.e., is an independent risk
factor for the disease
A B
C
28
How to control for confounding
• At the design phase
– Randomization
– Restriction
– Matching
• At the analysis phase
– Age-adjustment
– Stratification
– Multivariable adjustment
29
Matching is commonly used in CCS
• Control an extraneous variable by matching
controls to cases on a factor you know is an
important risk factor or marker for disease
• Example:
– Age (within 5 years)
– Sex
– Neighbourhood
• If factor is fixed to be the same in the cases
and controls then it can’t confound
30
Matching
• Analysis of matched CCS needs to account
for the matched case-control pairs
• Only pairs that are discordant with respect to
exposure provide useful information
• Can increase power by matching more than 1
control per case e.g., 4:1
• Useful if few cases are available
31
Recall Bias
• Form of measurement bias.
• Presence of disease may affect ability to recall or
report the exposure.
• Example – exposure to OTC drugs during pregnancy
use by moms of normal and congenitally abnormal
babies.
• To lessen potential:
• Blind participants to study hypothesis
• Blind study personnel to hypothesis
• Use explicit definitions for exposure
• Use controls with an unrelated but similar disease
– E.g., heart tetralogy (cases), hypospadia (controls)
32
CCS - Advantages
• Quick and cheap (relatively)
• so ideal for outbreaks
(http://www.cdc.gov/eis/casestudies/casestudies.htm)
• Can study rare diseases (or new)
• Can evaluate multiple exposures (fishing
trips)
33
Case-control Studies - Disadvantages
• uncertain of E D relationship (esp.
timing)
• cannot estimate disease rates
• worry about representativeness of controls
• inefficient if exposures are rare
• Bias:
• Selection
• Confounding
• Measurement (especially recall bias)
Thank you
Questions and Comments
34

More Related Content

What's hot

5. cohort studies
5. cohort  studies5. cohort  studies
5. cohort studies
Naveen Phuyal
 
Case control study
Case control studyCase control study
Case control study
Dr. Adrija Roy
 
Lecture 5 case control & cross-sectional spring 2013
Lecture 5  case control & cross-sectional spring 2013Lecture 5  case control & cross-sectional spring 2013
Lecture 5 case control & cross-sectional spring 2013maythayel
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2Rizwan S A
 
Case Study Control | Statistics
Case Study Control | StatisticsCase Study Control | Statistics
Case Study Control | Statistics
Transweb Global Inc
 
Case control studies
Case control studiesCase control studies
Case control studies
Ram Arya
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
INAAMUL HAQ
 
Analytical epidemiology
Analytical epidemiologyAnalytical epidemiology
Analytical epidemiology
Kaustubh Singh
 
Seminar case control study
Seminar case control studySeminar case control study
Seminar case control study
Radhika Maniyar
 
Case control studies
Case control studiesCase control studies
Case control studiesBruno Mmassy
 
Case control study by keshab chapagain
Case control study by keshab chapagainCase control study by keshab chapagain
Case control study by keshab chapagainKeshab Chapagain
 
Case control study
Case control studyCase control study
Case control study
Timiresh Das
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
Ismail Qamar
 
Epidemiology Study Design
Epidemiology Study DesignEpidemiology Study Design
Epidemiology Study Design
Mohammad Ismail Zubair MD. MSc
 
Cohort study and case control study
Cohort study and case control studyCohort study and case control study
Cohort study and case control study
Niv09
 
5. Case control
5. Case control5. Case control
5. Case control
Razif Shahril
 
Steps in cohort study
Steps in cohort studySteps in cohort study
Steps in cohort study
Sachin Patne
 
Malimu cohort studies
Malimu cohort studiesMalimu cohort studies
Malimu cohort studies
Miharbi Ignasm
 
Case control studies
Case control studiesCase control studies
Case control studies
keshavapavan
 
Case control studies..skp
Case control studies..skpCase control studies..skp
Case control studies..skpsudhiramkcg
 

What's hot (20)

5. cohort studies
5. cohort  studies5. cohort  studies
5. cohort studies
 
Case control study
Case control studyCase control study
Case control study
 
Lecture 5 case control & cross-sectional spring 2013
Lecture 5  case control & cross-sectional spring 2013Lecture 5  case control & cross-sectional spring 2013
Lecture 5 case control & cross-sectional spring 2013
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2
 
Case Study Control | Statistics
Case Study Control | StatisticsCase Study Control | Statistics
Case Study Control | Statistics
 
Case control studies
Case control studiesCase control studies
Case control studies
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
 
Analytical epidemiology
Analytical epidemiologyAnalytical epidemiology
Analytical epidemiology
 
Seminar case control study
Seminar case control studySeminar case control study
Seminar case control study
 
Case control studies
Case control studiesCase control studies
Case control studies
 
Case control study by keshab chapagain
Case control study by keshab chapagainCase control study by keshab chapagain
Case control study by keshab chapagain
 
Case control study
Case control studyCase control study
Case control study
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Epidemiology Study Design
Epidemiology Study DesignEpidemiology Study Design
Epidemiology Study Design
 
Cohort study and case control study
Cohort study and case control studyCohort study and case control study
Cohort study and case control study
 
5. Case control
5. Case control5. Case control
5. Case control
 
Steps in cohort study
Steps in cohort studySteps in cohort study
Steps in cohort study
 
Malimu cohort studies
Malimu cohort studiesMalimu cohort studies
Malimu cohort studies
 
Case control studies
Case control studiesCase control studies
Case control studies
 
Case control studies..skp
Case control studies..skpCase control studies..skp
Case control studies..skp
 

Similar to Epidemiological_Case_Control_Study_Design

EPI546_Lecture_9.ppt
EPI546_Lecture_9.pptEPI546_Lecture_9.ppt
EPI546_Lecture_9.ppt
Dhandapanikuppusamy
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1Rizwan S A
 
Case Control Studies.pptx
Case Control Studies.pptxCase Control Studies.pptx
Case Control Studies.pptx
SanjeevDavey1
 
Epidemiological Designs.ppt
Epidemiological Designs.pptEpidemiological Designs.ppt
Epidemiological Designs.ppt
reHANatabbasUm
 
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
AmirRaziq1
 
Case_Control_Study.pptx
Case_Control_Study.pptxCase_Control_Study.pptx
Case_Control_Study.pptx
Royal Dental College Library
 
ANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptx
payalrathod14
 
4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdf4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdf
mergawekwaya
 
STUDY DESIGN.pptx
STUDY   DESIGN.pptxSTUDY   DESIGN.pptx
STUDY DESIGN.pptx
GauravPurohit56
 
final.pptx
final.pptxfinal.pptx
final.pptx
Ritasman Baisya
 
Epidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptxEpidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptx
IsaacLalrawngbawla1
 
Chapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designsChapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designs
Omar Osman Eid
 
Case control study
Case control studyCase control study
Case control study
Abhijit Das
 
Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008
drtaa62
 
Case control study
Case control studyCase control study
Case control study
NayanaM13
 
Analytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptxAnalytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptx
drmamatanaik
 
Descriptive epidemiology
Descriptive epidemiologyDescriptive epidemiology
Descriptive epidemiology
Sonal Kale
 
Case control study
Case control studyCase control study
Case control study
BPKIHS
 
Research Designs
Research DesignsResearch Designs
Research DesignsAravind L R
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
jarati
 

Similar to Epidemiological_Case_Control_Study_Design (20)

EPI546_Lecture_9.ppt
EPI546_Lecture_9.pptEPI546_Lecture_9.ppt
EPI546_Lecture_9.ppt
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1
 
Case Control Studies.pptx
Case Control Studies.pptxCase Control Studies.pptx
Case Control Studies.pptx
 
Epidemiological Designs.ppt
Epidemiological Designs.pptEpidemiological Designs.ppt
Epidemiological Designs.ppt
 
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
 
Case_Control_Study.pptx
Case_Control_Study.pptxCase_Control_Study.pptx
Case_Control_Study.pptx
 
ANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptxANALYTICAL STUDIES.pptx
ANALYTICAL STUDIES.pptx
 
4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdf4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdf
 
STUDY DESIGN.pptx
STUDY   DESIGN.pptxSTUDY   DESIGN.pptx
STUDY DESIGN.pptx
 
final.pptx
final.pptxfinal.pptx
final.pptx
 
Epidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptxEpidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptx
 
Chapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designsChapter seven. epidemiologic study designs
Chapter seven. epidemiologic study designs
 
Case control study
Case control studyCase control study
Case control study
 
Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008
 
Case control study
Case control studyCase control study
Case control study
 
Analytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptxAnalytical epidemiology seminar 3.pptx
Analytical epidemiology seminar 3.pptx
 
Descriptive epidemiology
Descriptive epidemiologyDescriptive epidemiology
Descriptive epidemiology
 
Case control study
Case control studyCase control study
Case control study
 
Research Designs
Research DesignsResearch Designs
Research Designs
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 

More from Mohammad Ismail Zubair MD. MSc

Kandahar white area_mapping_summary_ppt_4_nov_2020
Kandahar white area_mapping_summary_ppt_4_nov_2020Kandahar white area_mapping_summary_ppt_4_nov_2020
Kandahar white area_mapping_summary_ppt_4_nov_2020
Mohammad Ismail Zubair MD. MSc
 
Health debates and dialogues final version
Health debates and dialogues final versionHealth debates and dialogues final version
Health debates and dialogues final version
Mohammad Ismail Zubair MD. MSc
 
Exploring the factors effecting mental health services
Exploring the factors effecting mental health servicesExploring the factors effecting mental health services
Exploring the factors effecting mental health services
Mohammad Ismail Zubair MD. MSc
 
Corss_sectional _study_ design
Corss_sectional _study_ designCorss_sectional _study_ design
Corss_sectional _study_ design
Mohammad Ismail Zubair MD. MSc
 
Snaphsot of ri's situation full version
Snaphsot of ri's situation full versionSnaphsot of ri's situation full version
Snaphsot of ri's situation full version
Mohammad Ismail Zubair MD. MSc
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
Mohammad Ismail Zubair MD. MSc
 
Barriers to routine_immunization_coverage_afghansitan_2018
Barriers to routine_immunization_coverage_afghansitan_2018Barriers to routine_immunization_coverage_afghansitan_2018
Barriers to routine_immunization_coverage_afghansitan_2018
Mohammad Ismail Zubair MD. MSc
 
Qualitative researc data_analysis
Qualitative researc data_analysisQualitative researc data_analysis
Qualitative researc data_analysis
Mohammad Ismail Zubair MD. MSc
 
Vpd surveillance system
Vpd surveillance systemVpd surveillance system
Vpd surveillance system
Mohammad Ismail Zubair MD. MSc
 
Introduction qualitative research_methodology_with_animation_fmic
Introduction qualitative  research_methodology_with_animation_fmicIntroduction qualitative  research_methodology_with_animation_fmic
Introduction qualitative research_methodology_with_animation_fmic
Mohammad Ismail Zubair MD. MSc
 

More from Mohammad Ismail Zubair MD. MSc (10)

Kandahar white area_mapping_summary_ppt_4_nov_2020
Kandahar white area_mapping_summary_ppt_4_nov_2020Kandahar white area_mapping_summary_ppt_4_nov_2020
Kandahar white area_mapping_summary_ppt_4_nov_2020
 
Health debates and dialogues final version
Health debates and dialogues final versionHealth debates and dialogues final version
Health debates and dialogues final version
 
Exploring the factors effecting mental health services
Exploring the factors effecting mental health servicesExploring the factors effecting mental health services
Exploring the factors effecting mental health services
 
Corss_sectional _study_ design
Corss_sectional _study_ designCorss_sectional _study_ design
Corss_sectional _study_ design
 
Snaphsot of ri's situation full version
Snaphsot of ri's situation full versionSnaphsot of ri's situation full version
Snaphsot of ri's situation full version
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
Barriers to routine_immunization_coverage_afghansitan_2018
Barriers to routine_immunization_coverage_afghansitan_2018Barriers to routine_immunization_coverage_afghansitan_2018
Barriers to routine_immunization_coverage_afghansitan_2018
 
Qualitative researc data_analysis
Qualitative researc data_analysisQualitative researc data_analysis
Qualitative researc data_analysis
 
Vpd surveillance system
Vpd surveillance systemVpd surveillance system
Vpd surveillance system
 
Introduction qualitative research_methodology_with_animation_fmic
Introduction qualitative  research_methodology_with_animation_fmicIntroduction qualitative  research_methodology_with_animation_fmic
Introduction qualitative research_methodology_with_animation_fmic
 

Recently uploaded

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 

Epidemiological_Case_Control_Study_Design

  • 1. 1 Case-Control Studies Dr. M. Ismail Zubair MD. MSc
  • 2. 2 Objectives - Concepts • Define, understand and identify (CCS) • Understand the principles of selecting cases and controls • Understand the analysis of CCS • Calculation and interpretation of the OR • Understand the concept of matching • Understand the origin and consequence of recall bias • Example of measurement bias • Advantages and disadvantages of CCS
  • 3. 3
  • 4. 4
  • 5. 5
  • 6. 6
  • 7. 7 Case-Control Studies (CCS) • An alternative observational design to identify risk factors for a disease/outcome. • Question: • How do diseased cases differ from non-diseased (controls) with respect to prior exposure history? • Compare frequency of exposure among cases and controls • Effect cause. • Cannot calculate disease incidence rates because the CCS does not follow a disease free- population over time
  • 8. 8
  • 9. 9
  • 10. 10
  • 11. 11
  • 12. 12
  • 13. 13 Disease + - Exp + a b Exp - c d d 1 d 0 Case-control Study – Design Select subjects on the basis of disease status
  • 14. 14 Example CCS - Smoking and Myocardial Infarction MI + - Smk + 30 20 Smk - 10 20 • 40 40 OR = a . d = 30 . 20 = 3.0 (same as the RR!) c . b 10 . 20 Study: Desert island, population = 2,000 people, prevalence of smoking = 50% [but this is unknown], identify all MI cases that occurred over last year (N=40), obtain a random sample of N=40 controls (no MI). What is the association between smoking and MI?
  • 15. 15 Examples of CCS • Outbreak investigations • What dish caused people at the church picnic to get sick? • What is causing young women to die of toxic shock? • Birth defects • Drug exposures and heart tetralogy • New (unrecognized) disease • DES and vaginal cancer in adolescents • Is smoking the reason for the increase in lung CA? (1940’s) – Four CCS implicating smoking and lung cancer appeared in 1950, establishing the CCS method in epidemiology
  • 16. 16 Essential features of CCS design • Directionality • Outcome to exposure • Timing • Retrospective for exposure, but case ascertainment can be either retrospective or prospective. • Rare or new disease • Design of choice if disease is rare or if a quick “answer” is needed (cohort design not useful) • Challenging • The most difficult type of study to design and execute • Design options • Population-based vs. hospital-based
  • 17. 17 Selection of Cases • Requires case-definition: • Need for standard diagnostic criteria e.g., AMI • Consider severity of disease? e.g., asthma • Consider duration of disease – prevalent or incident case? • Requires eligibility criteria • Area of residence, age, gender, etc
  • 18. 18 Sources of Cases • Population-based – identify and enroll all incident cases from a defined population – e.g., disease registry, defined geographical area, vital records • Hospital-based • identify cases where you can find them – e.g., hospitals, clinics. • But…… – issue of representativeness? – prevalent vs incident cases?
  • 19. 19 Selection of Controls • Controls reveal the ‘normal’ or ‘expected’ level of exposure in the population that gave rise to the cases. • Issue of comparability to cases – concept of the “study base” • Controls should be from the same underlying population or study base that gave rise to the cases? • Need to determine if the control had developed disease would he or she be included as a case in the study? – If no then do not include • Controls should have the same eligibility criteria as the cases
  • 20. 20 Sources of Controls • Population-based Controls – ideal, represents exposure distribution in the general population, e.g., • driver’s license lists (16+) • Medicare recipients (65+) • Tax lists • Voting lists • Telephone RDD survey • But if low participation rate = response bias (selection bias)
  • 21. 21 Sources of Controls • Hospital-based Controls • Hospital-based case control studies used when population- based studies not feasible • More susceptible to bias • Advantages – similar to cases? (hospital use means similar SES, location) – more likely to participate (they are sick) – efficient (interview in hospital) • Disadvantages – they have disease? • Don’t select if risk factor for their disease is similar to the disease under study e.g., COPD and Lung CA – are they representative of the study base?
  • 22. 22 Other Sources of Controls • Relatives, Neighbors, Friends of Cases • Advantages – similar to cases wrt SES/ education/ neighborhood – more willing to co-operate • Disadvantages – more time consuming – cases may not be willing to give information? – may have similar risk factors (e.g., smoke, alcohol, golf)
  • 23. 23 Disease case control Exp + a b Exp - c d d 1 d 0 • Odds of exposure among cases = a / c • Odds of exposure among controls = b / d
  • 24. 24 Analysis of CCS The OR as a measure of association • The only valid measure of association for the CCS is the Odds Ratio (OR) • Under reasonable assumptions (– the rare disease assumption) the OR approximates the RR. • OR = Odds of exposure among cases (disease) Odds of exposure among controls (non-dis) – Odds of exposure among cases = a / c – Odds of exposure among controls = b / d – Odds ratio = a/c = a.d [= cross-product ratio] b/d b.c
  • 25. 25 Example CCS - Smoking and Myocardial Infarction MI + - Smk + 30 20 Smk - 10 20 • 40 40 OR = a . d = 30 . 20 = 3.0 (same as the RR!) c . b 10 . 20 Study: Desert island, population = 2,000 people, prevalence of smoking = 50% [but this is unknown], identify all MI cases that occurred over last year (N=40), obtain a random sample of N=40 controls (no MI). What is the association between smoking and MI?
  • 26. 26 Odds Ratio (OR) • Similar interpretation as the Relative Risk • OR = 1.0 (implies equal odds of exposure - no effect) • ORs provide the exact same information as the RR if: • controls represent the target population • cases represent all cases • rare disease assumption holds (or if case-control study is undertaken with population-based sampling) • Remember: • OR can be calculated for any design but RR can only be calculated in RCT and cohort studies • The OR is the only valid measure for CCS • Publications will occasionally mis-label OR as RR (or vice versa)
  • 27. 27 Controlling extraneous variables (confounding) • Exposure of interest may be confounded by a factor that is associated with the exposure and the disease i.e., is an independent risk factor for the disease A B C
  • 28. 28 How to control for confounding • At the design phase – Randomization – Restriction – Matching • At the analysis phase – Age-adjustment – Stratification – Multivariable adjustment
  • 29. 29 Matching is commonly used in CCS • Control an extraneous variable by matching controls to cases on a factor you know is an important risk factor or marker for disease • Example: – Age (within 5 years) – Sex – Neighbourhood • If factor is fixed to be the same in the cases and controls then it can’t confound
  • 30. 30 Matching • Analysis of matched CCS needs to account for the matched case-control pairs • Only pairs that are discordant with respect to exposure provide useful information • Can increase power by matching more than 1 control per case e.g., 4:1 • Useful if few cases are available
  • 31. 31 Recall Bias • Form of measurement bias. • Presence of disease may affect ability to recall or report the exposure. • Example – exposure to OTC drugs during pregnancy use by moms of normal and congenitally abnormal babies. • To lessen potential: • Blind participants to study hypothesis • Blind study personnel to hypothesis • Use explicit definitions for exposure • Use controls with an unrelated but similar disease – E.g., heart tetralogy (cases), hypospadia (controls)
  • 32. 32 CCS - Advantages • Quick and cheap (relatively) • so ideal for outbreaks (http://www.cdc.gov/eis/casestudies/casestudies.htm) • Can study rare diseases (or new) • Can evaluate multiple exposures (fishing trips)
  • 33. 33 Case-control Studies - Disadvantages • uncertain of E D relationship (esp. timing) • cannot estimate disease rates • worry about representativeness of controls • inefficient if exposures are rare • Bias: • Selection • Confounding • Measurement (especially recall bias)
  • 34. Thank you Questions and Comments 34

Editor's Notes

  1. Italicized topics are covered in chapter but not in this lecture.
  2. Show Grimes’ taxonomy of studies diagram. Reviews the distinctions among the families of studies. Our interest today is in the center right – those (observational) studies in which the exposure is not manipulated and assigned, and the (analytical) studies in which there is a hypothesis being tested, which implies pre-planned comparison groups.
  3. Review of what case-control studies are – amass a group of cases and match with a group of controls (similar people without the outcome), then determine the likelihood of their having been exposed.
  4. Mis-classification of the exposure due to selective recall.
  5. Provide CDC website as tutorial for those interested in outbreak investigation.